Skip to main content
SleepCited

Melatonin के लिए नींद शुरू होने में कठिनाई

A संबंधित साक्ष्य कई बड़े नैदानिक परीक्षण लगातार महत्वपूर्ण लाभ दर्शाते हैं।

30 अध्ययनों (7 meta-analyses, 6 RCTs) पर आधारित, में कुल 10,634 प्रतिभागियों के साथ। 19/30 अध्ययन सकारात्मक प्रभाव दिखाते हैं।

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dsleep\u002Donset\u002Dlatency'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

निष्कर्ष

Melatonin is strongly supported by research as a supplement that may help you fall asleep faster, which is one of its best-established benefits.

  • 30 studies with 10,634 participants, including 7 meta-analyses and 6 RCTs
  • About 63% of studies confirm melatonin helps reduce the time it takes to fall asleep
  • Dose-response meta-analyses have helped identify effective dosing ranges
  • Recognized in clinical guidelines for both adults and children

Key Study Findings

review
Pediatric Insomnia.
Dose: Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other) बनाम: Placebo प्रभाव: CBT-I most effective treatment; melatonin beneficial in children with ASD or ADHD; limited evidence None
review
Unraveling the connection between the Mediterranean diet and sleep health: from biological mechanisms to clinical …
Dose: Mediterranean diet (high adherence vs. low adherence); polyphenols, omega-3, fiber as key components बनाम: Placebo प्रभाव: None None
animal study (preclinical)
The therapeutic potential of Ziziphi Spinosae Semen and Polygalae Radix in insomnia management: Insights from …
Dose: not specified (intragastric administration) बनाम: Placebo प्रभाव: None None
Meta-Analysis n=1689 Double-blind
Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of …
Dose: melatonin (various doses, peak efficacy at 4 mg/day) बनाम: Placebo प्रभाव: Melatonin reduces sleep onset latency and increases total sleep time, peaking at 4 mg/day; insomnia insomnia status p<0.001; time
animal study (preclinical) 4 weeks
Shen Yuan extract exerts a hypnotic effect via the tryptophan/5-hydroxytryptamine/melatonin pathway in mice.
Dose: 0.5 g/kg and 1.0 g/kg intragastrically बनाम: Placebo प्रभाव: None None

Key Statistics

30

अध्ययन

10634

प्रतिभागी

Positive

A

ग्रेड

Referenced Papers

Pediatrics in review 2026
Sleep medicine reviews 2022 48 उद्धरण
International journal of … 2022 25 उद्धरण
Chronobiology international 2021 47 उद्धरण
Continuum (Minneapolis, Minn.) 2017 132 उद्धरण
American family physician 2017 124 उद्धरण
The Cochrane database … 2014 131 उद्धरण
PloS one 2013 447 उद्धरण
Continuum (Minneapolis, Minn.) 2013 172 उद्धरण
Journal of pineal … 2012 322 उद्धरण
Sleep medicine reviews 2008 46 उद्धरण
Neuro endocrinology letters 2002
Journal of sleep … 1996 95 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
0.5-3 mg, 30-60 min before bed
jetlag:
0.5-5 mg

अधिकतम सीमा: No established UL; 5 mg typically considered maximum

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other) -- Positive --
Mediterranean diet (high adherence vs. low adherence); polyphenols, omega-3, fiber as key components -- Positive --
None -- Positive --
not specified (intragastric administration) -- Positive --
melatonin (various doses, peak efficacy at 4 mg/day) -- Positive 1689
0.5 g/kg and 1.0 g/kg intragastrically 4 weeks Positive --
low-dose melatonin administered 30-60 min before bedtime -- Positive --
variable (prolonged-release melatonin; ramelteon standard doses) -- Positive 4875

सेवन का सर्वोत्तम समय: 30-60 minutes before bed

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Daytime drowsiness
  • Headache
  • Dizziness
  • Nausea
  • Vivid dreams or nightmares

ज्ञात अंतःक्रियाएँ

  • Blood thinners (warfarin) — may increase bleeding risk
  • Immunosuppressants — melatonin may stimulate immune function
  • Diabetes medications — may affect blood sugar levels
  • Sedatives and CNS depressants — additive drowsiness

सहनीय अधिकतम सेवन: No established UL; 5 mg typically considered maximum

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Melatonin help with नींद शुरू होने में कठिनाई?
Based on 30 studies with 10,634 participants, there is strong evidence from multiple clinical trials that Melatonin may support नींद शुरू होने में कठिनाई management. Our evidence grade is A (Strong Evidence).
How much Melatonin should I take for नींद शुरू होने में कठिनाई?
Studies have used various dosages. A commonly studied range is 0.5-3 mg, 30-60 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Melatonin?
Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Melatonin and नींद शुरू होने में कठिनाई?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 30 peer-reviewed studies with 10,634 total participants. The overall direction of effect is positive.

इसके लिए अन्य सामग्री नींद शुरू होने में कठिनाई

References

  1. [1] Rayan Kteish et al.. Pediatr Rev. 2026. Pediatric Insomnia. doi:10.1542/pir.2024-006687 PubMed
  2. [2] Kacper Żełabowski et al.. Molecules. 2025. The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs. doi:10.3390/molecules30183814 PubMed
  3. [3] Tatiana Palotta Minari et al.. Sleep Breath. 2025. Unraveling the connection between the Mediterranean diet and sleep health: from biological mechanisms to clinical implications. doi:10.1007/s11325-025-03546-2 PubMed
  4. [4] Francy Cruz-Sanabria et al.. J Pineal Res. 2024. Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response … doi:10.1111/jpi.12985 PubMed
  5. [5] Oliviero Bruni et al.. Eur J Pediatr. 2024. European expert guidance on management of sleep onset insomnia and melatonin use in typically developing children. doi:10.1007/s00431-024-05556-w PubMed
  6. [6] Haiqin Ren et al.. J Ethnopharmacol. 2024. The therapeutic potential of Ziziphi Spinosae Semen and Polygalae Radix in insomnia management: Insights from gut microbiota and serum metabolomics … doi:10.1016/j.jep.2024.118255 PubMed
  7. [7] Tian-Ji Xia et al.. J Ethnopharmacol. 2024. Shen Yuan extract exerts a hypnotic effect via the tryptophan/5-hydroxytryptamine/melatonin pathway in mice. doi:10.1016/j.jep.2024.117992 PubMed
  8. [8] Julia Maruani et al.. J Sleep Res. 2023. Efficacy of melatonin and ramelteon for the acute and long-term management of insomnia disorder in adults: A systematic review and … doi:10.1111/jsr.13939 PubMed
  9. [9] Kyungseon Choi et al.. Sleep Med Rev. 2022. Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses. doi:10.1016/j.smrv.2022.101692 PubMed
  10. [10] Bárbara Carriedo-Diez et al.. Int J Environ Res Public Health. 2022. The Effects of the Exogenous Melatonin on Shift Work Sleep Disorder in Health Personnel: A Systematic Review. doi:10.3390/ijerph191610199 PubMed
  11. [11] Landon Hester et al.. Chronobiol Int. 2021. Evening wear of blue-blocking glasses for sleep and mood disorders: a systematic review. doi:10.1080/07420528.2021.1930029 PubMed
  12. [12] Huajun Xu et al.. Sleep Med. 2020. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial. doi:10.1016/j.sleep.2020.10.018 PubMed
  13. [13] Patrick Lemoine et al.. Complement Ther Med. 2019. A combination of melatonin, vitamin B6 and medicinal plants in the treatment of mild-to-moderate insomnia: A prospective pilot study. doi:10.1016/j.ctim.2019.05.024 PubMed
  14. [14] Athanasios Maras et al.. J Child Adolesc Psychopharmacol. 2018. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder. doi:10.1089/cap.2018.0020 PubMed
  15. [15] Vivien C Abad et al.. Drugs Aging. 2018. Insomnia in Elderly Patients: Recommendations for Pharmacological Management. doi:10.1007/s40266-018-0569-8 PubMed
  16. [16] Michael J Sateia et al.. J Clin Sleep Med. 2017. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice … doi:10.5664/jcsm.6470 PubMed
  17. [17] Paul Gringras et al.. J Am Acad Child Adolesc Psychiatry. 2017. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder. doi:10.1016/j.jaac.2017.09.414 PubMed
  18. [18] Milena Pavlova. Continuum (Minneap Minn). 2017. Circadian Rhythm Sleep-Wake Disorders. doi:10.1212/CON.0000000000000499 PubMed
  19. [19] Eric Matheson et al.. Am Fam Physician. 2017. Insomnia: Pharmacologic Therapy. PubMed
  20. [20] Yvan Touitou et al.. J Physiol Paris. 2016. Disruption of adolescents' circadian clock: The vicious circle of media use, exposure to light at night, sleep loss and risk … doi:10.1016/j.jphysparis.2017.05.001 PubMed
  21. [21] Juha Liira et al.. Cochrane Database Syst Rev. 2014. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. doi:10.1002/14651858.CD009776.pub2 PubMed
  22. [22] Eduardo Ferracioli-Oda et al.. PLoS One. 2013. Meta-analysis: melatonin for the treatment of primary sleep disorders. doi:10.1371/journal.pone.0063773 PubMed
  23. [23] Phyllis C Zee et al.. Continuum (Minneap Minn). 2013. Circadian rhythm abnormalities. doi:10.1212/01.CON.0000427209.21177.aa PubMed
  24. [24] Jessica R Barrett et al.. J Child Adolesc Psychopharmacol. 2013. To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and … doi:10.1089/cap.2013.0059 PubMed
  25. [25] Daniel P Cardinali et al.. J Pineal Res. 2012. Melatonin and its analogs in insomnia and depression. doi:10.1111/j.1600-079X.2011.00962.x PubMed
  26. [26] Wilfred R Pigeon et al.. J Med Food. 2010. Effects of a tart cherry juice beverage on the sleep of older adults with insomnia: a pilot study. doi:10.1089/jmf.2009.0096 PubMed
  27. [27] Michael J Sateia et al.. Sleep Med Rev. 2008. Efficacy and clinical safety of ramelteon: an evidence-based review. doi:10.1016/j.smrv.2007.12.005 PubMed
  28. [28] Louis J Mini et al.. Am J Geriatr Pharmacother. 2007. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty. doi:10.1016/j.amjopharm.2007.09.004 PubMed
  29. [29] Daniel P Cardinali et al.. Neuro Endocrinol Lett. 2002. Melatonin in sleep disorders and jet-lag. PubMed
  30. [30] C M Ellis et al.. J Sleep Res. 1996. Melatonin and insomnia. doi:10.1046/j.1365-2869.1996.00003.x PubMed

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।